Fig. 3From: Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological propertiesCombination of the ideal parameters to advance nose-to-brain delivery of neuroprotective therapy in TBIBack to article page